Biobank for Inflammatory Chronic Diseases and Osteoporosis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-99
SponsorUniversity Hospital, Toulouse
About this trial
The aim of this study is to constitute a biobank for patients followed in the Rheumatology center of Toulouse University Hospital for a chronic inflammatory rheumatism including rheumatoid arthritis (RA), spondyloarthritis(SpA), and psoriatic arthritis (PsA) or a chronic bone disease including osteoporosis in order to identify biomarkers associated with therapeutic response.
Eligibility criteria
Qualifiers
Chronic inflammatory rheumatism including RA, SpA or PsA or patients with primary or secondary osteoporosis
With National Health Assurance
Able to consent to the study
Disqualifiers
Pregnancy or breastfeeding
Not able to give a consent
Severe anemia (Hb<10g/L)
Trial design
Treatments tested in this trial
- Blood sampling
Treatment groups
2,000 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov